Bayer AG has entered into a takeover agreement with Cara Care
December 2024 — Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Cara Care is a digital digestive health solution from Germany that combines both mental and nutritional therapy options. Its MDR Class I-approved treatment for irritable bowel syndrome (IBS) is fully reimbursed by all German statutory health insurance (SHI) and DiGA-certified providers. DiGA refers to digital health applications that are approved for use in Germany and are eligible for reimbursement under the country’s SHI system. The company is a pioneer in the field and is driving growth in an underserved sector. Cara Care has built a product pipeline that addresses not only IBS but also heartburn, dyspepsia and inflammatory bowel disease (IBD).
Bayer AG is a global enterprise with core competencies in the life sciences fields of healthcare and agriculture. Founded in 1863 and headquartered in Leverkusen, Germany, Bayer is known for its innovation-driven approach to improving quality of life. The company operates across three main divisions: pharmaceuticals, consumer health and crop science, delivering products and solutions that address some of the world’s most pressing challenges, particularly in health and food security.
Our role in the transaction
Oaklins’ team in Germany provided comprehensive advisory services to the insolvency administrator and Cara Care in this transaction.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn more360 Experience Group has merged with GoodFellows
360 Experience Group, a European end-to-end service provider of live experiences, and GoodFellows have merged to create one of the largest live experiences players in Europe. By pooling their strengths under the 360 Experience Group banner, the merged group will span the full breadth of the live industry and bring together 16 specialized companies, including Live Legends, Unlimited Productions, Unbranded, TIG Sports and Events and Kumpany. The group will provide end-to-end solutions for the realization of large-scale live entertainment, international sports and public events and impactful brand activations. The combined business will generate over US$90 million in revenue and employ more than 230 people.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn more